ASCO and ESMO Lung Recap
GRACE
ASCO & ESMO Lung Recap on the IMpower010 Trial: Atezo After Chemo in Completely Resected Stage I-IIIA NSCLC
- 173 views
- February 9, 2022
GRACE
ASCO & ESMO Lung Recap: FDA Analysis of IO +/- Chemo in Advanced NSCLC and Low PD-L1
- 106 views
- February 9, 2022
GRACE
ASCO & ESMO Lung Recap on the Poseidon Trial: Durvalumab +/- Tremelimumab vs. Chemo Alone for mNSCLC
- 74 views
- February 9, 2022
GRACE
ASCO & ESMO Lung Recap: Carbo/Pemetrexed/Pembro and Acquired Resistance in EGFRm+ or ALK+ NSCLC
- 55 views
- February 9, 2022
GRACE
ASCO & ESMO Lung Recap on Sotorasib in KRAS G12C-Mutated NSCLC: CodeBreak 100 Trial
- 174 views
- February 9, 2022
- 1
GRACE
ASCO & ESMO Lung Recap on Amivantamab and Mobocertinib for EGFR Exon 20-Mutated NSCLC
- 168 views
- February 9, 2022
- 1
GRACE
ASCO & ESMO Lung Recap on Overall Biomarker Testing in MYLUNG Consortium
- 72 views
- February 9, 2022
- 1
GRACE
ASCO & ESMO Lung Recap: 2L Lurbinectedin in SCLC - Phase 3 Atlantis Trial
- 85 views
- February 9, 2022